Cargando…
Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048618/ https://www.ncbi.nlm.nih.gov/pubmed/30034548 http://dx.doi.org/10.1177/1758835918782356 |